5674
P. Tang et al. / Tetrahedron 68 (2012) 5668e5676
J¼2.4 Hz, H-17), 3.34 (3H, s, OCH3), 2.08, 2.01 (each 3H, s, OAcꢂ2),
1.07 (3H, t, J¼7.2 Hz, H3-22), 0.83 (3H, s, H3-18); 13C NMR (100 MHz,
CDCl3) see Table 1; ESIMS m/z 568 [MþH]þ; HR-ESIMS [MþH]þ m/z
calcd for C27H39NO7Br: 568.1910, found: 568.1920.
OCH2O), 3.66 (1H, t, J¼4.8 Hz, H-14
b), 3.43, 3.34, 3.27 (each 3H, s,
OCH3ꢂ3), 1.06 (3H, t, J¼6.8 Hz, H3-22), 0.78 (3H, s, H3-18); 13C NMR
(100 MHz, CDCl3) d 83.0 (d, C-1), 27.2 (t, C-2), 27.9 (t, C-3), 34.0 (s, C-
4), 49.2 (d, C-5), 37.4 (t, C-6), 90.6 (s, C-7), 81.7 (s, C-8), 47.6 (d, C-9),
43.6 (d, C-10), 50.9 (s, C-11), 32.6 (t, C-12), 38.1 (d, C-13), 81.8 (d, C-
14), 33.1 (t, C-15), 83.9 (d, C-16), 61.7 (d, C-17), 25.8 (q, C-18), 55.9 (t,
C-19), 50.6 (t, C-21), 14.0 (q, C-22), 93.3 (t, OCH2O), 55.7 (q, C-10),
57.7 (q, C-140), 56.3 (q, C-160); HR-ESIMS [MþH]þ m/z calcd for
C25H40NO5: 434.2906, found: 434.2897.
4.6.2. Compound 10. Mp:155e157 ꢀC;[
a]
D
20 ꢃ101.7 (c0.35,CHCl3);IR
(KBr): 2921,1738,1238 cmꢃ1; 1H NMR (400 MHz, CDCl3)
d
5.42 (1H, s,
H-6
J¼5.2 Hz, H-14
a
), 4.90 (2H, br s, OCH2O), 4.85 (2H, m, H-1þH-16
b), 4.72 (1H, t,
), 3.76 (1H, br s, H-17), 2.12, 2.06, 2.01 (each 3H, s,
b
OAcꢂ3), 1.10 (3H, t, J¼7.2 Hz, H3-22), 0.84 (3H, s, H3-18); 13C NMR
(100 MHz, CDCl3) see Table 1; ESIMS m/z 596 [MþH]þ; HR-ESIMS
[MþH]þ m/z calcd for C28H39NO8Br: 596.1859, found: 596.1849.
4.8. Preparation of compounds 14, 15, 16, 17, 18, and 19
Method 1: compound 13 (600 mg, 1.39 mmol) was dissolved in
a solution of 6.5% HBr in acetic acid (12 mL), and the reaction solution
was kept stirring at 80 ꢀC for 28 h before being poured into ice water
(50 mL). The mixture was basified with concd ammonium hydroxide
to pH >9, and extracted with dichloromethane (60 mLꢂ3). The
combined organic layers were rinsed with brine, dried (Na2SO4), and
concentrated under reduced pressure to furnish a residue, which was
subjected to column chromatography over silica gel, eluting with
petroleum ether/ethyl acetate (15:1), to give compounds 14 (white
amorphous powder, 129 mg, 19%), 15 (white amorphous powder,
134 mg, 20%),16 (white amorphous powder,106 mg,15%),17 (whiter
amorphous powder, 35 mg, 5%), 18 (white amorphous powder,
194 mg, 26%), and 19 (white amorphous powder, 33 mg, 6%).
Method 2: compound 13 (1.00 g, 2.31 mmol) was dissolved in
a solution of 3% HBr in acetic acid (30 mL), and the reaction solution
was kept stirring at 60 ꢀC for 24 h prior to being poured into ice
water (20 mL). The mixture was basified with concd ammonium
hydroxide to pH >9, and extracted with dichloromethane
(30 mLꢂ3). The combined extracts were rinsed with brine, dried
over anhydrous sodium sulfate, and concentrated under reduced
pressure to yield the crude product of compound 15. A solution of
the crude product 15 in 6.5% HBreHOAc (30 mL) was kept stirring
at 60 ꢀC for 50 h. Employing the similar work-up procedure de-
scribed for that of compound 15, the residue obtained was chro-
matographed over silica gel, eluting with petroleum ether/ethyl
acetate (10:1), to furnish compound 18 as a white amorphous
powder (557 mg, 45% from starting material 13).
4.6.3. Compound 11. Mp: 183e185 ꢀC; [
(KBr): 2951, 2883, 1742, 1368 cmꢃ1
a
]
20 ꢃ61.3 (c 0.15, CHCl3); IR
D
;
1H NMR (400 MHz, CDCl3)
d
6.11 (1H, dd, J¼9.6, 7.2 Hz, H-16), 5.63 (1H, dd, J¼9.6, 2.0 Hz, H-15),
5.43 (1H, s, H-6a), 5.02, 4.94 (each 1H, s, OCH2O), 4.71 (1H, t,
J¼4.0 Hz, H-14 ), 3.25 (3H, s, OCH3), 2.05, 2.02 (each 3H, s, OAcꢂ2),
b
1.04 (3H, t, J¼7.2 Hz, H3-22), 0.87 (3H, s, H3-18); 3C NMR (100 MHz,
CDCl3) see Table 1; ESIMS m/z 488 [MþH]þ; HR-ESIMS [MþH]þ m/z
calcd for C27H38NO7: 488.2648, found: 488.2660.
20
4.6.4. Compound 12. Mp: 193e195 ꢀC; [
a
]
ꢃ40.2 (c 0.50, CHCl3);
D
IR (KBr): 2961, 2933, 1740, 1369, 1245, 1084 cmꢃ1
(400 MHz, CDCl3) 5.36 (1H, s, H-6 ), 4.90, 4.81 (each 1H, s,
OCH2O), 4.80 (2H, m, H-14 ), 3.24 (3H, s, OCH3), 2.07, 2.03,
þH-16
;
1H NMR
d
a
b
a
2.02 (each 3H, s, OAcꢂ3), 1.04 (3H, t, J¼7.2 Hz, H3-22), 0.82 (3H, s,
H3-18); 13C NMR (100 MHz, CDCl3) see Table 1; ESIMS m/z 548
[MþH]þ; HR-ESIMS [MþH]þ m/z calcd for C29H42NO9: 548.2860,
found: 548.2854.
4.7. Preparation of compound 13
Compound 8 (8.2 g, 16.70 mmol) was dissolved in a solution of
5% NaOH in methanol (150 mL), and the reaction mixture was kept
stirring at 50 ꢀC for 30 min before being cooled down to room
temperature. After removal of methanol, the residue was sus-
pended with water (100 mL), and the subsequent mixture was
extracted with dichloromethane (100 mLꢂ3). The combined ex-
tracts were rinsed with brine, dried (Na2SO4), and concentrated
under reduced pressure to furnish an alcohol product (pale yellow
amorphous powder, 7.45 g). To a solution of the alcohol (7.45 g)
made above in DMF (150 mL) were added carbon disulfide (20 mL,
332.8 mmol) and a solution of 20% NaOH in water (10 mL) at 0 ꢀC,
and the red-brown reaction solution was kept stirring at the same
temperature for 1 h prior to the slow addition of methyl iodide
(10.3 mL, 165.3 mmol). The reaction was allowed to proceed at 0 ꢀC
for an additional 4 h prior to being quenched with water (150 mL).
The subsequent mixture was extracted with dichloromethane
(150 mLꢂ3), and the combined extracts were dried (Na2SO4) and
concentrated under reduced pressure. The residue obtained was
purified by column chromatography, eluting with petroleum ether/
acetone (10:1), to give a xanthate (yellow oil, 8.5 g). To a solution of
the xanthate (8.5 g) prepared above in toluene (150 mL) were se-
quentially added AIBN (65 mg, 0.39 mmol) and n-Bu3SnH (6.3 mL,
23.64 mmol), and the reaction mixture was refluxed for 2 h. After
cooling down to room temperature and removal of toluene, the
residue was suspended with water (80 mL), and the mixture was
extracted with dichloromethane (100 mLꢂ3). The combined ex-
tracts were dried over anhydrous sodium sulfate and concentrated
under reduced pressure to give a residue, which was subjected to
column chromatography over silica gel, using petroleum ether/ac-
etone (20:1) as eluent, to furnish compound 13 as a white amor-
phous powder (6.4 g, 88% from starting material 8). Mp: 99e101 ꢀC;
4.8.1. Compound 14. Mp: 99e101 ꢀC; [
a]
D
20 ꢃ16.7 (c 1.15, CHCl3); IR
(KBr): 2963, 2930, 2873, 1733, 1369, 1253, 1081 cmꢃ1
;
1H NMR
(400 MHz, CDCl3)
J¼5.2 Hz, H-14 ), 4.77 (1H, dd, J¼9.6, 4.8 Hz, H-16
), 3.23 (3H, s, OCH3), 2.11, 2.00
d
4.97, 4.92 (each 1H, s, OCH2O), 4.84 (1H, t,
), 3.05 (1H, br s, H-
b
a
17), 3.02 (1H, dd, J¼10.4, 7.2 Hz, H-1
b
(each 3H, s, OAcꢂ2), 1.05 (3H, t, J¼7.2 Hz, H3-22), 0.76 (3H, s, H3-18);
13C NMR (100 MHz, CDCl3) see Table 2; ESIMS m/z 490 [MþH]þ; HR-
ESIMS [MþH]þ m/z calcd for C27H40NO7: 490.2805, found: 490.2805.
20
4.8.2. Compound 15. Mp: 172e174 ꢀC; [
a
]
ꢃ65.0 (c 0.40, CHCl3);
D
IR (KBr): 2881, 1459, 1370, 1120, 1081 cmꢃ1
CDCl3)
3.08 (1H, dd, J¼10.8, 6.8 Hz, H-1), 1.98 (1H, m, H-2
(1H, overlapped, H-2 ), 1.20 (1H, m, H-3 ), 1.63 (1H, m, H-3
(1H, overlapped, H-5), 1.32 (1H, overlapped, H-6
;
1H NMR (400 MHz,
d
a), 2.35
b
a
b
), 1.32
a), 2.12 (1H, m, H-
6b
), 2.45 (1H, overlapped, H-9), 1.82 (1H, overlapped, H-10), 1.82
(1H, overlapped, H-12 ), 2.45 (1H, overlapped, H-12 ), 2.58 (1H, m,
H-13), 3.56 (1H, t, J¼4.4 Hz, H-14 ), 2.20 (1H, m, H-15 ), 2.35 (1H,
overlapped, H-15 ), 4.85 (1H, m, H-16), 3.57 (1H, s, H-17), 0.78 (3H,
a
b
b
a
b
s, H3-18), 2.45 (1H, overlapped, H-19a), 2.61 (1H, d, J¼11.6 Hz, H-
19b), 2.70 (1H, m, H-21a), 2.83 (1H, m, H-21b), 1.07 (3H, t, J¼7.2 Hz,
H3-22), 5.05, 4.93 (each 1H, s, OCH2O), 3.33 (3H, s, 1-OCH3), 3.42
(3H, s, 14-OCH3); 13C NMR (100 MHz, CDCl3) see Table 2; HR-ESIMS
[MþH]þ m/z calcd for C24H37NO4Br: 482.1906, found: 482.1897.
20
[
a]
20 ꢃ35.6 (c 0.50, CHCl3); IR (KBr): 2963, 2931, 2898, 2823, 1460,
4.8.3. Compound 16. Mp: 174e176 ꢀC; [
a
]
D
ꢃ70.8 (c 0.25, CHCl3);
D
1380, 1079 cmꢃ1; 1H NMR (400 MHz, CDCl3)
d
5.02, 4.92 (each 1H, s,
IR (KBr): 2926, 2882, 1741, 1368, 1239, 1083 cmꢃ1 1H NMR
;